Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for excessive sleepiness in pediatric OSAHS
NCT00107809Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of modafinil in obstructive sleep apnea syndrome (OSAS) (4 arms), sponsored by Cephalon, Inc. Primary endpoints: Mean Sleep Latency from Multiple Sleep Latency Test at Week 6 and Clinical Global Impression of Change at Week 6. Started Oct 2004; status: completed.
02
Drugs
modafinil
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT00107809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107809.